Abstract
This study examined the expression and potential mechanism of microRNA (miRNA)-424-5p in nasopharyngeal carcinoma (NPC). NPC tissues were collected from 40 patients who were enrolled in the study, and skin samples were collected from 26 healthy subjects during plastic surgery as controls. We performed various in vitro assays using miR-424-5p to examine its function in primary NPC-1 cells. Bioinformatics was employed to analyze potential target genes and signaling pathways of miR-424-5p. We found that miR-424-5p expression in NPC tissues is downregulated and negatively correlated with lymph node metastasis and clinical staging. Expression of miR-424-5p in NPC cells was also downregulated, and transfection with miR-424-5p mimics inhibited proliferation, migration, and invasion of NPC-1 cells. Bioinformatics identified the AKT3 gene as a potential target of miR-424-5p and dual luciferase assays confirmed this finding. Upregulation of AKT3 expression rescued the inhibitory effect of miR-424-5p on the proliferation, migration, and invasion. Our results suggest that miR-424-5p inhibited the proliferation, migration, and invasion of NPC cells by decreasing AKT3 expression.
References
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jul 22, 2014·Oncogene·B-S LiG Guo
Oct 27, 2015·International Journal of Molecular Medicine·Wei-Lu WuGan-Di Li
Oct 21, 2016·Journal of Neuro-oncology·Anna JoyBurt G Feuerstein
Aug 9, 2016·Molecular Carcinogenesis·Meichun ZhangZhaohui Liu
Sep 16, 2016·Diagnostic Pathology·Feng WangLiuxing Wang
Jan 10, 2017·Expert Opinion on Therapeutic Targets·SubbaRao V Madhunapantula, Gavin P Robertson
Jan 14, 2017·Life Sciences·Yan ZhouXian-Lan Zhao
May 20, 2017·Oncotarget·Song WeiZekuan Xu
Nov 28, 2017·Molecular Carcinogenesis·Lanfang ZhangYongmei Qin
Dec 8, 2017·Journal of Cachexia, Sarcopenia and Muscle·Martin ConnollyPaul R Kemp
Dec 13, 2017·Cell Cycle·Jingjing LiuXingsheng Yang
Jan 13, 2018·Genes & Cancer·Pourya Naderi YeganehM Taghi Mostafavi
Feb 7, 2018·Cancer Management and Research·Hsiao-Fei LeeTsair-Fwu Lee
Feb 8, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ya-Nan JinHao-Yuan Mo
Feb 8, 2018·Cancer Letters·Shuangbing XuKunyu Yang
Feb 8, 2018·International Journal of Radiation Oncology, Biology, Physics·Yi LiYamei Tang
Feb 8, 2018·International Journal of Radiation Oncology, Biology, Physics·Wai-Tong NgAnne W M Lee
Feb 8, 2018·Translational Oncology·Ting JinXiao-Zhong Chen
Feb 9, 2018·Oncotarget·Weiwei LaiYongguang Tao
Feb 9, 2018·Oncotarget·Mingyu DuLi Yin
Feb 10, 2018·Acta Biochimica Et Biophysica Sinica·Zhongqi LiYan Huang
Feb 10, 2018·Acta Biomaterialia·You Lang ZhouJin Bo Tang
Feb 10, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Peng YeXinghua Long
Feb 10, 2018·Translational Oncology·Fangzheng WangYangming Jiang